Kleanthis G. Xanthopoulos
2014 - Regulus Therapeutics
In 2014, Kleanthis G. Xanthopoulos earned a total compensation of $3.9M as Former President Chief Executive Officer at Regulus Therapeutics, a 48% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $533,952 |
|---|---|
| Option Awards | $2,743,355 |
| Salary | $618,000 |
| Other | $7,343 |
| Total | $3,902,650 |
Xanthopoulos received $2.7M in option awards, accounting for 70% of the total pay in 2014.
Xanthopoulos also received $534K in non-equity incentive plan, $618K in salary and $7.3K in other compensation.
Rankings
In 2014, Kleanthis G. Xanthopoulos' compensation ranked 2,184th out of 13,032 executives tracked by ExecPay. In other words, Xanthopoulos earned more than 83.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,184 out of 13,032 | 83rd |
Division Manufacturing | 775 out of 4,965 | 84th |
Major group Chemicals And Allied Products | 244 out of 1,690 | 86th |
Industry group Drugs | 189 out of 1,369 | 86th |
Industry Pharmaceutical Preparations | 155 out of 1,042 | 85th |
Source: SEC filing on April 22, 2016.
Xanthopoulos' colleagues
We found three more compensation records of executives who worked with Kleanthis G. Xanthopoulos at Regulus Therapeutics in 2014.